Department of Obstetrics and Gynecology, Rabin Medical Center, Helen Schneider Hospital for Women, 49100, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Arch Gynecol Obstet. 2019 Aug;300(2):305-312. doi: 10.1007/s00404-019-05184-y. Epub 2019 May 5.
To evaluate the efficacy of cerclage in preventing preterm birth according to indication.
Retrospective analysis of all women who underwent cerclage to prevent preterm birth in a university-affiliated medical-center (2007-2017). Multiple gestations were excluded. Cohort was divided to three subgroups according to cerclage indication: group A-primary prevention cerclage, performed during the first trimester, based on a history of cervical insufficiency; group B-secondary prevention cerclage, performed after sonographic visualization of asymptomatic cervical length shortening and previous preterm birth; and group C-tertiary prevention cerclage, performed at mid-trimester in women presenting with asymptomatic cervical dilatation. Primary outcome was gestational age at delivery. Secondary outcomes were maternal and neonatal complications.
During the study period 273 women underwent cervical cerclage: group A-215 (79%), group B-25 (9%), and group C-33 (12%). Patients in group C had significantly lower gravidity and parity. Gestational age at cerclage was highest in group C and lowest in group A (22 vs. 13 weeks p < 0.001). Median gestational age at delivery was 37 + 3 weeks in groups A and B and 34 + 3 in group C. This difference persisted after controlling for potential confounders (p < 0.0001). Preterm birth prior to 34 weeks of gestation were 10.7% in group A, 16% in group B, and 33.33% in group C (p = 0.0021). Neonatal complications including: respiratory distress syndrome, intraventricular hemorrhage, and necrotizing enterocolitis, were clmore prevalent in group C.
Cerclage was shown to be an acceptable measure in cases of an anticipated increased risk of preterm birth with a low rate of procedure associated complications. However, the number-needed-to-treat cannot be determined from our data, because a control group was lacking.
根据指征评估宫颈环扎术预防早产的疗效。
对在大学附属医院行宫颈环扎术预防早产的所有妇女(2007-2017 年)进行回顾性分析。排除多胎妊娠。根据宫颈环扎指征将队列分为三组:A 组-一级预防宫颈环扎术,在孕早期进行,基于宫颈机能不全病史;B 组-二级预防宫颈环扎术,在超声发现无症状宫颈缩短和既往早产史后进行;C 组-三级预防宫颈环扎术,在无症状宫颈扩张的孕妇中于孕中期进行。主要结局是分娩时的孕龄。次要结局是母婴并发症。
研究期间,273 名妇女接受了宫颈环扎术:A 组-215 例(79%),B 组-25 例(9%),C 组-33 例(12%)。C 组患者的孕次和产次明显较低。C 组的宫颈环扎孕周最高,A 组最低(22 周比 13 周,p<0.001)。A 组和 B 组的中位分娩孕周为 37+3 周,C 组为 34+3 周。在控制潜在混杂因素后,这一差异仍然存在(p<0.0001)。A 组<34 孕周早产率为 10.7%,B 组为 16%,C 组为 33.33%(p=0.0021)。C 组新生儿并发症包括呼吸窘迫综合征、颅内出血和坏死性小肠结肠炎更为常见。
宫颈环扎术在预期早产风险增加的情况下是一种可接受的措施,且手术相关并发症发生率低。然而,由于缺乏对照组,我们的数据无法确定需要治疗的人数。